About Tomas Heyman
Form D filings for Legend Biotech in 2023 list Tomas Heyman as director.
Tomas Heyman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Tomas Heyman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Tomas Heyman works with at each company, as listed on that company's latest Form D.
Legend Biotech Corp · Form D, Apr 28, 2023
LM
Li Mao, MD
Director
FD
Fangliang Zhang, Ph.D.
Director
DD
Darren Ji, M.D., Ph.D.
Director
LD
Li Zhu, Ph.D.
Director
LM
Lori Macomber
Chief Financial Officer
PD
Patrick Casey, Ph.D.
Director
YS
Ye Wang, M.S.
Director
PC
Philip Yau, CPA
Director
YD
Ying Huang, Ph.D.
Executive officer and director
CD
Corazon Sanders, Ph.D.
Director